RecallRadar

FDA Drug recall D-0045-2021

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single…

On 2020-10-28 the FDA classified a Class III recall of Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single… by Ani Pharmaceuticals, citing labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0045-2021
ClassificationClass III
Statusterminated
Initiated2020-10-09
Published2020-10-28
Last updated2026-09-13 11:52 UTC
CompanyAni Pharmaceuticals
DistributionUS

Product

Dextroamphetamine Saccharate, Amphetamine Aspartate Monohydrate, Dextroamphetamine Sulfate and Amphetamine Sulfate (Mixed Salts of A Single-Entity Amphetamine Product) Extended-Release Capsules, 15 mg, 100-count bottle, Rx Only, Mfd. for: Amerigen Pharmaceuticals, Inc. Lyndhurst, NJ 07071 NDC 43975-279-10

Reason

Labeling: Incorrect expiration date. Product dated with 24-month expiration date instead of 18-months.

Identifiers

ndc43975-277-10
ndc43975-278-10
ndc43975-279-10
ndc43975-280-10
ndc43975-282-10
ndc43975-281-10
code_infoLot: 19T14 Exp. Dec. 2021, 20D06 Exp. Apr. 2022

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0045-2021%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.